Annovis Bio, Inc. (ANVS)
NYSE·Healthcare·Biotechnology
$1.82
-0.55%
Mkt Cap $50.56M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (3 analysts)
$25.67
Range $21.00 – $30.00
Implied Upside
+1310.4%
Consensus $25.67 vs current $1.82
NYSE·Healthcare·Biotechnology
$1.82
-0.55%
Mkt Cap $50.56M
Buy
1
Hold
0
Sell
0
Price Target (3 analysts)
$25.67
Range $21.00 – $30.00
+1310.4%
Consensus $25.67 vs current $1.82